Correlation Between Molecular Partners and Keros Therapeutics
Can any of the company-specific risk be diversified away by investing in both Molecular Partners and Keros Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Molecular Partners and Keros Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Molecular Partners AG and Keros Therapeutics, you can compare the effects of market volatilities on Molecular Partners and Keros Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Molecular Partners with a short position of Keros Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Molecular Partners and Keros Therapeutics.
Diversification Opportunities for Molecular Partners and Keros Therapeutics
-0.09 | Correlation Coefficient |
Good diversification
The 3 months correlation between Molecular and Keros is -0.09. Overlapping area represents the amount of risk that can be diversified away by holding Molecular Partners AG and Keros Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Keros Therapeutics and Molecular Partners is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Molecular Partners AG are associated (or correlated) with Keros Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Keros Therapeutics has no effect on the direction of Molecular Partners i.e., Molecular Partners and Keros Therapeutics go up and down completely randomly.
Pair Corralation between Molecular Partners and Keros Therapeutics
Given the investment horizon of 90 days Molecular Partners AG is expected to under-perform the Keros Therapeutics. In addition to that, Molecular Partners is 1.93 times more volatile than Keros Therapeutics. It trades about -0.01 of its total potential returns per unit of risk. Keros Therapeutics is currently generating about -0.01 per unit of volatility. If you would invest 5,964 in Keros Therapeutics on August 31, 2024 and sell it today you would lose (109.00) from holding Keros Therapeutics or give up 1.83% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Molecular Partners AG vs. Keros Therapeutics
Performance |
| Timeline |
| Molecular Partners |
| Keros Therapeutics |
Molecular Partners and Keros Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Molecular Partners and Keros Therapeutics
The main advantage of trading using opposite Molecular Partners and Keros Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Molecular Partners position performs unexpectedly, Keros Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Keros Therapeutics will offset losses from the drop in Keros Therapeutics' long position.| Molecular Partners vs. Mineralys Therapeutics, Common | Molecular Partners vs. AN2 Therapeutics | Molecular Partners vs. Pharvaris BV | Molecular Partners vs. PepGen |
| Keros Therapeutics vs. Ideaya Biosciences | Keros Therapeutics vs. AnaptysBio | Keros Therapeutics vs. MeiraGTx Holdings PLC | Keros Therapeutics vs. Janux Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the FinTech Suite module to use AI to screen and filter profitable investment opportunities.
Other Complementary Tools
| Share Portfolio Track or share privately all of your investments from the convenience of any device | |
| Content Syndication Quickly integrate customizable finance content to your own investment portal | |
| Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
| Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing |